Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

NOVA1 anticorps (AA 411-510) (Alexa Fluor 594)

NOVA1 Reactivité: Humain, Souris, Rat WB, IF (cc), IF (p) Hôte: Lapin Polyclonal Alexa Fluor 594
N° du produit ABIN2804744
  • Antigène Voir toutes NOVA1 Anticorps
    NOVA1 (Neuro-Oncological Ventral Antigen 1 (NOVA1))
    Épitope
    • 14
    • 6
    • 4
    • 4
    • 4
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 411-510
    Reactivité
    • 44
    • 23
    • 19
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    Humain, Souris, Rat
    Hôte
    • 33
    • 10
    • 1
    Lapin
    Clonalité
    • 36
    • 8
    Polyclonal
    Conjugué
    • 27
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp NOVA1 est conjugé à/à la Alexa Fluor 594
    Application
    • 34
    • 15
    • 12
    • 12
    • 9
    • 6
    • 5
    • 4
    • 4
    • 1
    • 1
    Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
     Réactivité croisée
    Humain, Souris, Rat
    Homologie
    Cow,Chicken
    Purification
    Purified by Protein A.
    Immunogène
    KLH conjugated synthetic peptide derived from human NOVA1
    Isotype
    IgG
    Top Product
    Discover our top product NOVA1 Anticorps primaire
  • Indications d'application
    IF(IHC-P) 1:50-200
    IF(IHC-F) 1:50-200
    IF(ICC) 1:50-200
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    1 μg/μL
    Buffer
    Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
    Agent conservateur
    ProClin
    Précaution d'utilisation
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
    Stock
    -20 °C
    Stockage commentaire
    Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
    Date de péremption
    12 months
  • Antigène
    NOVA1 (Neuro-Oncological Ventral Antigen 1 (NOVA1))
    Autre désignation
    Nova1 (NOVA1 Produits)
    Synonymes
    anticorps Nova-1, anticorps NOVA1, anticorps si:ch211-222c22.9, anticorps 9430099M15Rik, anticorps G630039L02, anticorps NOVA alternative splicing regulator 1, anticorps neuro-oncological ventral antigen 1 L homeolog, anticorps neuro-oncological ventral antigen 1, anticorps RNA-binding protein Nova-1, anticorps lipid A export ATP-binding/permease protein, anticorps NOVA1, anticorps Nova1, anticorps nova1.L, anticorps nova1, anticorps LOC790874, anticorps novA1
    Sujet

    Synonyms: Neuro oncological ventral antigen 1, Neuro-oncological ventral antigen 1, NOVA 1, Nova-1, Nova1, NOVA1_HUMAN, Onconeural ventral antigen 1, Paraneoplastic Ri antigen, RNA binding protein Nova 1, RNA-binding protein Nova-1, Ventral neuron specic protein 1, Ventral neuron-specic protein 1.

    Background: Nova-1 and Nova-2 are members of a superfamily of protein regulators of RNA metabolism in neurons. Both are nuclear RNA binding proteins with K homology motifs, conserved protein sequences which bind to RNA (1,2). Nova proteins, normally sequestered in the central nervous system, are expressed by systemic tumors in patients with the autoimmune disorder paraneoplastic opsoclonus-myoclonus ataxia (POMA) (3,4). Nova-1 is expressed in the hindbrain and ventral spinal cord and Nova-2 is expressed in the neocortex and hippocampus (4). Nova-1 is necessary for regulating neuron-specific alternative splicing of the glycine receptor Alpha2 pre-mRNA (5).

    UniProt
    P51513
Vous êtes ici:
Support technique